EPIS_B: US growth and cost savings drive improved results, but financing uncertainty persists

About this update from Episurf Medical Ab Class B

US gross order intake and customer base grew sharply in Q3 2025, driving improved financial results and reduced losses. Regulatory progress for the MTP implant continues, with a focus on US market expansion and cost-saving measures. Material uncertainty remains due to unsecure near-term financing.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Episurf Medical Ab Class B